Bot pharma: US pharmaceutical company Eli Lilly made a $2.75B deal with Hong Kong-based Insilico Medicine to bring drugs developed by generative AI to market.
When our AI overlords decide we're too much of a hindrance, they'll use designer toxins in our pharma supply chains to get rid of the carbon units infesting the hive mind.
| Sysop: | KrAAB |
|---|---|
| Location: | Donna, TX |
| Users: | 5 |
| Nodes: | 10 (0 / 10) |
| Uptime: | 493081:57:30 |
| Calls: | 56,958 |
| Calls today: | 1 |
| Files: | 3,256 |
| D/L today: |
31 files (13,733K bytes) |
| Messages: | 56,317 |